Multiple primary neoplasia of kidney, prostate and colon

Gallyamov, E. A.; Agapov, M. A.; Кубышкин, В А; Биктимиров, Р. Г.; Малахов, П. С.; Zryanin, A. M.; Камалов, А А; Луцевич, О. Э.

doi:10.17116/hirurgia2018498-100

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Information about multiple primary genitourinary cancers, which include PCa as primary or secondary, is very rare. Many articles published about MPN cancers are included in the literature as case reports and longterm follow-up is not available for PCa [7][8][9][10]. The presence of PCa in metachronous tumours is valuable in the light of this information.…”

Section: Introductionmentioning

confidence: 99%

Prognosis of primary or metachronous prostate cancer in multiple primary genitourinary cancers; a single center experience with long-term results

Ediz¹,

Akan²,

Tavukçu³

et al. 2021

The Aging Male

View full text Add to dashboard Cite

Objective: This study aims to analyze the challenges, approaches and long-term results of primary or metachronous prostate cancer (PCa) in cases with multiple primary genitourinary cancers. Methodology: A total of 17 patients were included in the study. Patients with multiple primary genitourinary cancers were divided into two groups according to the diagnosis of primary or metachronous PCa as group 1 and group 2. Results: The median age of patients was similar in both groups. The median smoking status (pack-years) was higher in group 2 than group 1. The median prostate-specific antigen (PSA) level was higher in group 1 than group 2. The median follow-up time from primary to the metachronous tumour was higher in group 1 than group 2. The rate of recurrence in PCa was higher in group 1 than group 2. No statistically significant difference was observed in terms of patients' age, smoking status, PSA levels at diagnosis of PCa and biochemical recurrence or metastasis between the two groups (p > 0.05) Conclusion: Primary PCa cases may progress more aggressively than metachronous PCa cases. Biochemical recurrence and metastasis may be less threatening in metachronous PCa cases than primary cases. Therefore, aggressive treatment can be avoided for metachronous PCa cases.

show abstract

Section: Introductionmentioning

confidence: 99%